- Home
- LTM vs BMRN Comparison
LTM vs BMRN Comparison
Compare LTM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTM
- BMRN
- Stock Information
- Founded
- LTM 1929
- BMRN 1996
- Country
- LTM Chile
- BMRN United States
- Employees
- LTM N/A
- BMRN N/A
- Industry
- LTM
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LTM
- BMRN Health Care
- Exchange
- LTM NYSE
- BMRN Nasdaq
- Market Cap
- LTM 12.6B
- BMRN 12.1B
- IPO Year
- LTM N/A
- BMRN 1999
- Fundamental
- Price
- LTM $41.91
- BMRN $59.01
- Analyst Decision
- LTM Strong Buy
- BMRN Buy
- Analyst Count
- LTM 3
- BMRN 23
- Target Price
- LTM $38.00
- BMRN $93.73
- AVG Volume (30 Days)
- LTM 422.5K
- BMRN 1.9M
- Earning Date
- LTM 01-01-0001
- BMRN 08-04-2025
- Dividend Yield
- LTM 1.52%
- BMRN N/A
- EPS Growth
- LTM 49.49
- BMRN 152.82
- EPS
- LTM 0.00
- BMRN 2.71
- Revenue
- LTM $12,914,322,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- LTM $8.51
- BMRN $12.27
- Revenue Next Year
- LTM $4.63
- BMRN $9.99
- P/E Ratio
- LTM $11.85
- BMRN $21.81
- Revenue Growth
- LTM 6.41
- BMRN 19.36
- 52 Week Low
- LTM $21.83
- BMRN $52.93
- 52 Week High
- LTM $43.07
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- LTM N/A
- BMRN 55.66
- Support Level
- LTM N/A
- BMRN $56.48
- Resistance Level
- LTM N/A
- BMRN $60.43
- Average True Range (ATR)
- LTM 0.00
- BMRN 1.52
- MACD
- LTM 0.00
- BMRN 0.23
- Stochastic Oscillator
- LTM 0.00
- BMRN 64.05
About LTM LATAM AIRLINES GROUP SA SPON ADS EACH REP 2000 SHS
LATAM Airlines Group SA operates as a passenger airline group. The company and its affiliates provide domestic services in Brazil, Chile, Peru, Colombia, and Ecuador, as well as regional flights and long-haul operations. LATAM group carries out cargo operations using both belly space on passenger flights and dedicated freighter aircraft. In addition, it also offers complementary services, such as ground handling, courier, logistics, and maintenance. Geographically, the group generates maximum revenue from Brazil, followed by Chile, the United States of America, Peru, Europe, Colombia, Ecuador, Asia Pacific, and the rest of Latin America.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.